berezko /
10 March 2017Americas

PTAB upholds Acorda’s Ampyra patents in Kyle Bass case

The Patent Trial and Appeal Board upheld Acorda Therapeutics’ patents covering the drug Ampyra (dalfampridine) in a case against Kyle Bass’s Coalition for Affordable Drugs in a decision handed down yesterday.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at